Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the opioid crisis.
Category: Purdue Pharma
-
Jillian Sackler, Philanthropist Who Defended Husband’s Legacy, Dies at 84
Though the Sackler name was tarnished over Purdue Pharma’s role in the opioid crisis, Arthur Sackler’s should not be, she insisted; a company founder, he died well before the trouble began.
-
Ex-McKinsey Partner Sentenced in Obstruction Case
The consultant had deleted records involving McKinsey’s role in pushing OxyContin sales and driving the opioid crisis.
-
Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition
A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars from the settlement in a legal-defense fund for the family.
-
Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.
-
McKinsey to Pay $650 Million in Opioid Settlement With Justice Department
A senior partner has also pleaded to obstruction of justice after destroying company documents.
-
Sacklers Threatened with Lawsuits from States and Creditors for Purdue Pharma
Legal maneuverings followed a Supreme Court ruling last month that denied the Sackler family immunity from liability over its role in the opioid crisis.
-
Purdue Opioid Settlement on Verge of Collapse After Supreme Court Ruling
Plaintiffs and the company vowed to renegotiate but the talks will be challenging after the court struck down a provision the Sacklers had insisted on in exchange for $6 billion.
-
Supreme Court Rejects Liability Shield at Center of Purdue Pharma Settlement
The liability shield would have protected members of the Sackler family from civil claims related to the opioid epidemic.
-
McKinsey Is Under Criminal Investigation for Its Opioid Work
Federal prosecutors are examining the consulting company’s role in helping “turbocharge” the sale of painkillers like OxyContin.
-
National Academy Asks Court to Strip Sackler Name From Endowment
Millions in Sackler donations sat dormant, rising in value as the opioid epidemic raged and as other institutions distanced themselves from the makers of a notorious painkiller.
-
Supreme Court to Hear Challenge to Controversial Purdue Pharma Deal
The justices will hear arguments on Monday about whether members of the wealthy Sackler family can be shielded from liability through a bankruptcy settlement.